• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A method for reducing misclassification in the extended Glasgow Outcome Score.一种降低扩展格拉斯哥结局评分中误分类的方法。
J Neurotrauma. 2010 May;27(5):843-52. doi: 10.1089/neu.2010.1293.
2
Inter-rater agreement on assessment of outcome within a trauma registry.创伤登记系统中对结果评估的评分者间一致性。
Injury. 2016 Jan;47(1):130-4. doi: 10.1016/j.injury.2015.08.002. Epub 2015 Aug 10.
3
Questionnaires vs Interviews for the Assessment of Global Functional Outcomes After Traumatic Brain Injury.问卷与访谈在评估创伤性脑损伤后整体功能结局中的比较。
JAMA Netw Open. 2021 Nov 1;4(11):e2134121. doi: 10.1001/jamanetworkopen.2021.34121.
4
Validity and sensitivity to change of the extended Glasgow Outcome Scale in mild to moderate traumatic brain injury.轻度至中度创伤性脑损伤中扩展格拉斯哥预后量表的效度及对变化的敏感性
J Neurotrauma. 2001 Jun;18(6):575-84. doi: 10.1089/089771501750291819.
5
Reliability of ratings on the Glasgow Outcome Scales from in-person and telephone structured interviews.通过面对面和电话结构化访谈得出的格拉斯哥预后量表评分的可靠性。
J Head Trauma Rehabil. 2003 May-Jun;18(3):252-8. doi: 10.1097/00001199-200305000-00003.
6
Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.格拉斯哥预后量表和扩展格拉斯哥预后量表的结构化访谈:使用指南
J Neurotrauma. 1998 Aug;15(8):573-85. doi: 10.1089/neu.1998.15.573.
7
Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials.格拉斯哥预后量表错误分类对创伤性脑损伤临床试验的影响。
J Neurotrauma. 2008 Jun;25(6):641-51. doi: 10.1089/neu.2007.0510.
8
Diagnosing the GOSE: Structural and Psychometric Properties Using Item Response Theory, a TRACK-TBI Pilot Study.诊断 GOSE:使用项目反应理论的结构和心理计量学特性,TRACK-TBI 初步研究。
J Neurotrauma. 2019 Sep 1;36(17):2493-2505. doi: 10.1089/neu.2018.5998. Epub 2019 May 23.
9
[French version of structured interviews for the Glasgow Outcome Scale: guidelines and first studies of validation].[格拉斯哥预后量表结构化访谈的法语版本:指南及首次效度研究]
Ann Readapt Med Phys. 2004 May;47(4):142-56. doi: 10.1016/j.annrmp.2004.01.004.
10
Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?扩展格拉斯哥结局量表是否比传统格拉斯哥结局量表更有价值?
J Neurotrauma. 2012 Jan 1;29(1):53-8. doi: 10.1089/neu.2011.2137.

引用本文的文献

1
Prognostic utility of somatosensory evoked potentials in supratentorial hemorrhage-induced prolonged disorders of consciousness.体感诱发电位在幕上出血所致长时间意识障碍中的预后效用
Eur J Med Res. 2025 Aug 13;30(1):744. doi: 10.1186/s40001-025-03027-y.
2
Role of disturbance coefficient in monitoring and treatment of cerebral edema in patients with cerebral hemorrhage.干扰系数在脑出血患者脑水肿监测与治疗中的作用
World J Clin Cases. 2025 May 16;13(14):102534. doi: 10.12998/wjcc.v13.i14.102534.
3
Revisiting the critical roles of reactive microglia in traumatic brain injury.重新审视反应性小胶质细胞在创伤性脑损伤中的关键作用。
Int J Surg. 2025 Jun 1;111(6):3942-3978. doi: 10.1097/JS9.0000000000002420. Epub 2025 May 12.
4
Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury.多模态评估可提高脑损伤且临床无反应的重症监护患者的神经预后性能。
Nat Med. 2024 Aug;30(8):2349-2355. doi: 10.1038/s41591-024-03019-1. Epub 2024 May 30.
5
Early sedation in traumatic brain injury: a multicentre international observational study.创伤性脑损伤的早期镇静:一项多中心国际观察性研究。
Crit Care Resusc. 2023 Oct 16;24(4):319-329. doi: 10.51893/2022.4.OA2. eCollection 2022 Dec 5.
6
Stem Cell Therapy in Children with Traumatic Brain Injury.儿童创伤性脑损伤的干细胞治疗。
Int J Mol Sci. 2023 Sep 28;24(19):14706. doi: 10.3390/ijms241914706.
7
Covert Tracking to Immersive Stimuli in Traumatic Brain Injury Subjects With Disorders of Consciousness.意识障碍创伤性脑损伤患者对沉浸式刺激的隐蔽追踪
J Neurotrauma. 2024 Mar;41(5-6):646-659. doi: 10.1089/neu.2023.0188. Epub 2023 Oct 16.
8
Long-Term Outcomes among Patients with Prolonged Disorders of Consciousness.长期意识障碍患者的远期预后。
Brain Sci. 2023 Jan 23;13(2):194. doi: 10.3390/brainsci13020194.
9
Nanoparticle-based drug delivery for the treatment of traumatic brain injury.基于纳米颗粒的药物递送治疗创伤性脑损伤。
Expert Opin Drug Deliv. 2023 Jan;20(1):55-73. doi: 10.1080/17425247.2023.2152001. Epub 2022 Dec 6.
10
Cognitive-motor dissociation and time to functional recovery in patients with acute brain injury in the USA: a prospective observational cohort study.美国急性脑损伤患者认知-运动分离与功能恢复时间:一项前瞻性观察队列研究。
Lancet Neurol. 2022 Aug;21(8):704-713. doi: 10.1016/S1474-4422(22)00212-5.

本文引用的文献

1
Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.加权kappa系数:用于衡量名义尺度上的一致性,并考虑了尺度不一致或部分得分的情况。
Psychol Bull. 1968 Oct;70(4):213-20. doi: 10.1037/h0026256.
2
Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials.格拉斯哥预后量表错误分类对创伤性脑损伤临床试验的影响。
J Neurotrauma. 2008 Jun;25(6):641-51. doi: 10.1089/neu.2007.0510.
3
Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trial.创伤性脑损伤结局评估中的观察者差异:来自一项多中心、国际随机临床试验的经验。
Neurosurgery. 2007 Jul;61(1):123-8; discussion 128-9. doi: 10.1227/01.neu.0000279732.21145.9e.
4
A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury.一项关于缓激肽B2受体拮抗剂阿那替班(LF16 - 0687Ms)在重度创伤性脑损伤患者中进行的单剂量、三臂、安慰剂对照的I期研究。
J Neurotrauma. 2005 Dec;22(12):1444-55. doi: 10.1089/neu.2005.22.1444.
5
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.右泛醇治疗重度创伤性脑损伤的疗效与安全性:一项III期随机、安慰剂对照临床试验的结果
Lancet Neurol. 2006 Jan;5(1):38-45. doi: 10.1016/S1474-4422(05)70253-2.
6
Clinical trials in head injury.头部损伤的临床试验。
J Neurotrauma. 2002 May;19(5):503-57. doi: 10.1089/089771502753754037.
7
Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma.严重神经创伤临床试验中主要结局指标的错误分类与治疗效果
J Neurotrauma. 2002 Jan;19(1):17-22. doi: 10.1089/089771502753460204.
8
Intercenter variance in clinical trials of head trauma--experience of the National Acute Brain Injury Study: Hypothermia.头部创伤临床试验中的中心间差异——国家急性脑损伤研究:低温治疗的经验
J Neurosurg. 2001 Nov;95(5):751-5. doi: 10.3171/jns.2001.95.5.0751.
9
Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.缓激肽拮抗剂Bradycor(地替班特,CP-1027)对重度创伤性脑损伤的影响:一项多中心、随机、安慰剂对照试验的结果。美国脑损伤协会研究小组。
J Neurotrauma. 1999 Jun;16(6):431-44. doi: 10.1089/neu.1999.16.431.
10
Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations.为何近期针对脑损伤的神经保护剂试验未能显示出令人信服的疗效?一项务实分析与理论思考。
Neurosurgery. 1999 Jun;44(6):1286-98.

一种降低扩展格拉斯哥结局评分中误分类的方法。

A method for reducing misclassification in the extended Glasgow Outcome Score.

机构信息

Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia 23298-0508, USA.

出版信息

J Neurotrauma. 2010 May;27(5):843-52. doi: 10.1089/neu.2010.1293.

DOI:10.1089/neu.2010.1293
PMID:20334503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2943940/
Abstract

The eight-point extended Glasgow Outcome Scale (GOSE) is commonly used as the primary outcome measure in traumatic brain injury (TBI) clinical trials. The outcome is conventionally collected through a structured interview with the patient alone or together with a caretaker. Despite the fact that using the structured interview questionnaires helps reach agreement in GOSE assessment between raters, significant variation remains among different raters. We introduce an alternate GOSE rating system as an aid in determining GOSE scores, with the objective of reducing inter-rater variation in the primary outcome assessment in TBI trials. Forty-five trauma centers were randomly assigned to three groups to assess GOSE scores on sample cases, using the alternative GOSE rating system coupled with central quality control (Group 1), the alternative system alone (Group 2), or conventional structured interviews (Group 3). The inter-rater variation between an expert and untrained raters was assessed for each group and reported through raw agreement and with weighted kappa (kappa) statistics. Groups 2 and 3 without central review yielded inter-rater agreements of 83% (weighted kappa = 0.81; 95% CI 0.69, 0.92) and 83% (weighted kappa = 0.76, 95% CI 0.63, 0.89), respectively, in GOS scores. In GOSE, the groups had an agreement of 76% (weighted kappa = 0.79; 95% CI 0.69, 0.89), and 63% (weighted kappa = 0.70; 95% CI 0.60, 0.81), respectively. The group using the alternative rating system coupled with central monitoring yielded the highest inter-rater agreement among the three groups in rating GOS (97%; weighted kappa = 0.95; 95% CI 0.89, 1.00), and GOSE (97%; weighted kappa = 0.97; 95% CI 0.91, 1.00). The alternate system is an improved GOSE rating method that reduces inter-rater variations and provides for the first time, source documentation and structured narratives that allow a thorough central review of information. The data suggest that a collective effort can be made to minimize inter-rater variation.

摘要

八点扩展格拉斯哥结局量表(GOSE)常用于创伤性脑损伤(TBI)临床试验的主要结局指标。结果通常通过与患者单独或与护理人员一起进行结构化访谈来收集。尽管使用结构化访谈问卷有助于在 GOSE 评估中达成评估者之间的一致意见,但不同评估者之间仍然存在显著差异。我们引入了一种替代的 GOSE 评分系统,作为确定 GOSE 评分的辅助手段,目的是减少 TBI 试验中主要结局评估的评估者间变异性。45 个创伤中心被随机分配到三组,使用替代 GOSE 评分系统结合中心质量控制(第 1 组)、单独使用替代系统(第 2 组)或常规结构化访谈(第 3 组)评估样本病例的 GOSE 评分。评估了每个组中专家和非训练评估者之间的组内变异性,并通过原始一致性和加权 Kappa(kappa)统计报告。没有中心审查的第 2 组和第 3 组的组内一致性分别为 83%(加权 Kappa=0.81;95%CI 0.69,0.92)和 83%(加权 Kappa=0.76,95%CI 0.63,0.89),GOS 评分。在 GOSE 中,这三组的一致性分别为 76%(加权 Kappa=0.79;95%CI 0.69,0.89)和 63%(加权 Kappa=0.70;95%CI 0.60,0.81)。在使用替代评分系统结合中心监测的组中,三个组中 GOS 的组内一致性最高(97%;加权 Kappa=0.95;95%CI 0.89,1.00)和 GOSE(97%;加权 Kappa=0.97;95%CI 0.91,1.00)。替代系统是一种改进的 GOSE 评分方法,可降低评估者间的变异性,并首次提供源文档和结构化叙述,允许对信息进行彻底的中心审查。数据表明,可以共同努力最大限度地减少评估者间的变异性。